Raymond James Financial Services Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $8.25M | Buy |
130,306
+33,401
| +34% | +$2.11M | 0.01% | 960 |
|
|
2024
Q2 | $5.14M | Sell |
96,905
-999
| -1% | -$53K | 0.01% | 1149 |
|
|
2024
Q1 | $8.03M | Sell |
97,904
-49,548
| -34% | -$4.06M | 0.01% | 912 |
|
|
2023
Q4 | $2.74M | Buy |
147,452
+13,097
| +10% | +$244K | ﹤0.01% | 1396 |
|
|
2023
Q3 | $1.49M | Sell |
134,355
-8,849
| -6% | -$98K | ﹤0.01% | 1678 |
|
|
2023
Q2 | $2.32M | Buy |
143,204
+39,857
| +39% | +$646K | ﹤0.01% | 1426 |
|
|
2023
Q1 | $1.72M | Sell |
103,347
-25,360
| -20% | -$422K | ﹤0.01% | 1571 |
|
|
2022
Q4 | $1.21M | Sell |
128,707
-14,500
| -10% | -$136K | ﹤0.01% | 1712 |
|
|
2022
Q3 | $390K | Buy |
143,207
+1,626
| +1% | +$4.43K | ﹤0.01% | 2401 |
|
|
2022
Q2 | $409K | Sell |
141,581
-2,951
| -2% | -$8.53K | ﹤0.01% | 2398 |
|
|
2022
Q1 | $434K | Sell |
144,532
-32,117
| -18% | -$96.4K | ﹤0.01% | 2461 |
|
|
2021
Q4 | $813K | Sell |
176,649
-4,874
| -3% | -$22.4K | ﹤0.01% | 2095 |
|
|
2021
Q3 | $1.14M | Buy |
181,523
+18,860
| +12% | +$118K | ﹤0.01% | 1869 |
|
|
2021
Q2 | $974K | Sell |
162,663
-770
| -0.5% | -$4.61K | ﹤0.01% | 1960 |
|
|
2021
Q1 | $1.03M | Buy |
163,433
+28,588
| +21% | +$181K | ﹤0.01% | 1840 |
|
|
2020
Q4 | $759K | Buy |
134,845
+21,505
| +19% | +$121K | ﹤0.01% | 1885 |
|
|
2020
Q3 | $660K | Sell |
113,340
-9,798
| -8% | -$57.1K | ﹤0.01% | 1804 |
|
|
2020
Q2 | $888K | Buy |
123,138
+39,136
| +47% | +$282K | ﹤0.01% | 1564 |
|
|
2020
Q1 | $393K | Buy |
84,002
+12,654
| +18% | +$59.2K | ﹤0.01% | 1677 |
|
|
2019
Q4 | $572K | Sell |
71,348
-301
| -0.4% | -$2.41K | ﹤0.01% | 1882 |
|
|
2019
Q3 | $493K | Buy |
71,649
+24,171
| +51% | +$166K | ﹤0.01% | 1909 |
|
|
2019
Q2 | $394K | Buy |
47,478
+12,764
| +37% | +$106K | ﹤0.01% | 2079 |
|
|
2019
Q1 | $345K | Buy |
34,714
+12,453
| +56% | +$124K | ﹤0.01% | 2148 |
|
|
2018
Q4 | $170K | Buy |
+22,261
| New | +$170K | ﹤0.01% | 2305 |
|